» Articles » PMID: 14675066

Urine Protein Profiling with Surface-enhanced Laser-desorption/ionization Time-of-flight Mass Spectrometry

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2003 Dec 17
PMID 14675066
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the last few years there has been an increasing interest in exploring the human proteome. In particular, efforts have focused on developing strategies to generate reproducible protein maps of normal cells, tissues, and biologic fluids, from which studies can then compare protein expression between different groups (e.g., healthy individuals vs. those with a specific pathologic state).

Methods: Various extrinsic factors (instrument settings, matrix composition, urine storage post void, freeze-thaw cycles) and intrinsic factors (blood in urine, urine dilution, first-void vs. midstream urine) were analyzed with respect to their impact on urine protein profiling using surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

Results: Extrinsic factors that critically influenced reproducibility and peak detection of urine protein profiling were matrix composition and instrument settings, while freeze-thaw cycles had minimal impact. Midstream urines samples did not undergo changes in their protein profile when stored for three days at 4 degrees C. Intrinsic factors that influenced normal urine protein profiling were blood in the urine and urine dilution. Female first-void urine had a significantly different ratio of proteins present compared to a midstream urine sample. Limitations of the SELDI-TOF-MS technique included ion suppression and quantification of individual proteins when protein composition was complex.

Conclusion: SELDI-TOF-MS offers a unique platform for high throughput urine protein profiling; however, standardization of analysis conditions is critical, and both extrinsic and intrinsic factors must be taken into account for accurate data interpretation.

Citing Articles

Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet's disease uveitis.

Qin W, Liang A, Han X, Zhang M, Gao Y, Zhao C BMC Ophthalmol. 2024; 24(1):277.

PMID: 38982370 PMC: 11232131. DOI: 10.1186/s12886-024-03557-9.


Comparison of clean catch and bag urine using LC-MS/MS proteomics in infants.

Klaus R, Barth T, Imhof A, Thalmeier F, Lange-Sperandio B Pediatr Nephrol. 2023; 39(1):203-212.

PMID: 37523035 PMC: 10673958. DOI: 10.1007/s00467-023-06098-3.


Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease Diagnosis.

Baldan-Martin M, Chaparro M, Gisbert J Int J Mol Sci. 2023; 24(12).

PMID: 37373307 PMC: 10299330. DOI: 10.3390/ijms241210159.


Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer.

Bararia A, Chakraborty P, Roy P, Chattopadhay B, Das A, Chatterjee A World J Gastroenterol. 2023; 29(15):2241-2260.

PMID: 37124888 PMC: 10134423. DOI: 10.3748/wjg.v29.i15.2241.


Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial: rational and protocol.

Thijs L, Asayama K, Maestre G, Hansen T, Buyse L, Wei D Blood Press. 2021; 30(5):269-281.

PMID: 34461803 PMC: 9412130. DOI: 10.1080/08037051.2021.1952061.